The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9340517, 71 ID: ALA3985613
PubChem CID: 57853990
Max Phase: Preclinical
Molecular Formula: C35H40N4O2
Molecular Weight: 548.73
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CNCCC[C@@H]1N[C@H](CNC(=O)c2ccc3ccccc3c2)CCN(CC(c2ccccc2)c2ccccc2)C1=O
Standard InChI: InChI=1S/C35H40N4O2/c1-36-21-10-17-33-35(41)39(25-32(27-12-4-2-5-13-27)28-14-6-3-7-15-28)22-20-31(38-33)24-37-34(40)30-19-18-26-11-8-9-16-29(26)23-30/h2-9,11-16,18-19,23,31-33,36,38H,10,17,20-22,24-25H2,1H3,(H,37,40)/t31-,33-/m0/s1
Standard InChI Key: FMQCPFGNUAWQSN-WEZIJMHWSA-N
Molfile:
RDKit 2D
41 45 0 0 1 0 0 0 0 0999 V2000
-3.9356 -6.0845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7643 -5.8239 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7488 -6.9290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2838 -6.6031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7317 -7.7082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1986 -7.3818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5374 -5.9206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2403 -5.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5691 -7.3934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6298 -8.5630 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2799 -9.9178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7763 -10.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4256 -11.3861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9211 -11.5034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5673 -12.8571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7180 -14.0936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2226 -13.9764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5764 -12.6227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6239 -8.7945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1197 -8.9070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9651 -7.6680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3148 -6.3163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8190 -6.2037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9736 -7.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1298 -8.5578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6054 -9.6372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
6 5 1 6
6 7 1 0
7 8 1 0
8 9 1 6
9 10 1 0
10 11 1 0
11 12 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 16 1 0
21 22 2 0
22 13 1 0
8 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
27 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 34 1 0
25 40 1 0
40 6 1 0
40 41 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 548.73Molecular Weight (Monoisotopic): 548.3151AlogP: 4.96#Rotatable Bonds: 11Polar Surface Area: 73.47Molecular Species: BASEHBA: 4HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 10.24CX LogP: 4.68CX LogD: 1.66Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.23Np Likeness Score: -0.13
References 1. (2016) Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor,